Abstract
The various scaling methodologies and molecular features analysis were applied to new dataset to predict human pharmacokinetics studies. Whereas the predictive accuracies demonstrated across all of the various methodologies were lower for this higher clearance compound dataset, scaling from species continued to be an accurate methodology, and human volume of distribution was similarly well predicted regardless of scaling methodology. Also, extrapolation is the method for constructing new data points given a set of discrete data points. Methods estimate is reasonably reliable for short times, but for longer times, the estimate is liable to become less accurate. Species Scaling and Extrapolation are useful for acquiring toxicological data- epidemiological and experimental study. Animal studies help us to understand toxicity characteristics of a chemical before human exposure is allowed, whereas the epidemiological method generally does not. Species scaling and extrapolation from animals is necessary in many cases which helps in dealing with the socalled human risks more properly.
Keywords: Species scaling, extrapolation, pharmacokinetics, clearance, metabolism
Current Drug Metabolism
Title: Species Scaling and Extrapolation
Volume: 9 Issue: 3
Author(s): Virendra S. Gomase and Somnath Tagore
Affiliation:
Keywords: Species scaling, extrapolation, pharmacokinetics, clearance, metabolism
Abstract: The various scaling methodologies and molecular features analysis were applied to new dataset to predict human pharmacokinetics studies. Whereas the predictive accuracies demonstrated across all of the various methodologies were lower for this higher clearance compound dataset, scaling from species continued to be an accurate methodology, and human volume of distribution was similarly well predicted regardless of scaling methodology. Also, extrapolation is the method for constructing new data points given a set of discrete data points. Methods estimate is reasonably reliable for short times, but for longer times, the estimate is liable to become less accurate. Species Scaling and Extrapolation are useful for acquiring toxicological data- epidemiological and experimental study. Animal studies help us to understand toxicity characteristics of a chemical before human exposure is allowed, whereas the epidemiological method generally does not. Species scaling and extrapolation from animals is necessary in many cases which helps in dealing with the socalled human risks more properly.
Export Options
About this article
Cite this article as:
Gomase S. Virendra and Tagore Somnath, Species Scaling and Extrapolation, Current Drug Metabolism 2008; 9 (3) . https://dx.doi.org/10.2174/138920008783884786
DOI https://dx.doi.org/10.2174/138920008783884786 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nuclear PI-PLCβ1 and Myelodysplastic Syndromes: Genetics and Epigenetics
Current Pharmaceutical Design Systemic Redox Biomarkers in Neurodegenerative Diseases
Current Drug Metabolism Immunotoxicity and Immunogenicity of Biopharmaceuticals: Design Concepts and Safety Assessment
Current Drug Safety Development of Small Molecule HIV-1 Fusion Inhibitors: Linking Biology to Chemistry
Current Pharmaceutical Design Drugs and Rhabdomyolysis: From Liver to Kidney
Current Vascular Pharmacology HIV-1 Replication from After Cell Entry to the Nuclear Periphery
Current HIV Research Drosophila Models of Proteinopathies: the Little Fly that Could
Current Pharmaceutical Design Loop Gain and Sleep Disordered Breathing
Current Respiratory Medicine Reviews Biotransformation of Silybin and its Congeners
Current Drug Metabolism Peptide-Based Inhibitors of the HIV Envelope Protein and Other Class I Viral Fusion Proteins
Current Pharmaceutical Design From Ontology-Based Gene Function to Physiological Model
Current Bioinformatics Cell-Selective Mitochondrial Targeting: Progress in Mitochondrial Medicine
Current Drug Delivery Autoimmune Diabetes Mellitus: The Importance of Autoantibodies for Disease Prediction and Diagnostic Support
Current Immunology Reviews (Discontinued) Coagulation Disorders in Acute Lung Injury
Current Respiratory Medicine Reviews Molecular Targets for the Treatment of Multiple Myeloma
Current Cancer Drug Targets Current Protein-based Anti-angiogenic Therapeutics
Mini-Reviews in Medicinal Chemistry Molecular Insights and Therapeutic Targets in Amyotrophic Lateral Sclerosis
CNS & Neurological Disorders - Drug Targets Bilirubin Chemistry and Metabolism; Harmful and Protective Aspects
Current Pharmaceutical Design Regulatory Mechanisms of Cardiac Development and Repair
Cardiovascular & Hematological Disorders-Drug Targets Signaling Pathways Underpinning the Manifestations of Ionizing Radiation-Induced Bystander Effects
Current Molecular Pharmacology